27 Apr 2015 07:00
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Board Appointment
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that Colin King has agreed to join the Board as Chief Operating Officer and will take up his appointment with effect from 3 August 2015.
Mr King has over 20 years' experience in the in-vitro diagnostics industry and is currently the Managing Director of Axis-Shield Diagnostics, having joined in 1995 and held a number of positions encompassing project management, operations, planning and supply chain logistics.
Andrew Shepherd, Chief Executive of the Company said:"We would like to welcome Colin to the Board. He brings a wealth of relevant industry experience and his depth of knowledge of the in-vitro diagnostics sector will further strengthen the Omega Board."
The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies:
Mr Colin King, age 46
Current Directorships / Partnerships:
None
Previous Directorships / Partnerships (held in the past five years)
Axis-Shield Diagnostics Ltd
Axis-Shield Limited
Axis-Shield Laboratory Products
Mr King does not currently hold any ordinary shares in the Company. There are no other disclosures required in relation to Rule 17 or paragraph (g) of Schedule 2 of the AIM Rules for Companies.
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 or www.omegadiagnostics.com |
Andrew Shepherd, Chief Executive |
|
Kieron Harbinson, Group Finance Director Jag Grewal, Group Sales and Marketing Director |
|
|
|
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/James Thompson (Corporate Finance) Mia Gardner (Corporate Broking) |
|
|
|
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |